The filing further said that "it is bioequivalent to the reference listed drug product (RLD), Colcrys tablets, 0.6 mg, of Takeda Pharmaceuticals USA, Inc." Shares of Granules India were trading at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results